Monday, September 29, 2025 Market indexes spent all day in the green today, continuing new all-time high levels through a few news items throughout the day. Not all of it is positive, however: a ...
Novo Nordisk NVO announced positive data from a sub-analysis of its phase III REDEFINE 1 study assessing the efficacy and safety of once-weekly cagrilintide 2.4 mg as a monotherapy, alongside ...